MRI of the Liver With Eovist
Terminated
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- NCT01215838
- Lead Sponsor
- University of Washington
- Brief Summary
The purpose of this study is to determine if a new magnetic resonance (MR) protocol is better at diagnosing liver lesions.
- Detailed Description
Hepatocellular carcinoma (HCC), a form of liver cancer, is the seventh most common cause of cancer mortality in the US. The incidence rate of HCC is increasing along with the incidence of Hepatitis B and C which are known to promote HCC. Patients have a better prognosis (survival outlook) if HCC is found and treated at an early stage. MRI is the best imaging modality for diagnosing HCC.
This study will compare standard MRIs and MRIs performed with a newly developed MR protocol to determine if it is possible to more confidently diagnose HCC.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- known hepatocellular carcinoma
- undergoing MRI of the liver
Read More
Exclusion Criteria
- Contraindication to MRI with IV contrast
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Accuracy of a new MR protocol in diagnosing HCC and other liver lesions. One day: participants will have one MRI of the liver.
- Secondary Outcome Measures
Name Time Method